Merck Enters Obesity Space, Buys Rights to Hansoh's Oral GLP-1 Drug
Merck gets exclusive global rights to develop, manufacture and commercialize GLP-1 receptor agonist, HS-10535, from Hansoh ...
MSD makes obesity play in up to $2bn deal for Hansoh’s GLP-1RA asset
MSD is also betting on Hansoh’s candidate working in more indications than just obesity. The drugmaker already has a ...
AARP6d
How to Lose Weight in Your Face
And the growing popularity of a new generation of weight loss drugs has led to the use of the term “Ozempic face,” which refers to sagging, wrinkling and other facial changes experienced by some ...
Merck Snags Chinese Obesity Drug in Nearly $2 Billion Deal
Merck & Co. snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as $2 billion.
Investor's Business Daily on MSN6d
Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else
Merck threw its hat into the obesity race on Wednesday, inking a deal worth up to $2.01 billion with Hansoh Pharma for its weight-loss drug.
Merck Joins With Chinese Distributor On Weight Loss Pill
( MENAFN - Baystreet) Merck (NYSE:MRK) on Wednesday said it has snagged the rights to an experimental weight loss pill from ...